[Webinar] A Closer Look at the Potential of CRISPR/Cas9 in Duchenne – December 2016
[Webinar] A Closer Look at the Potential of CRISPR/Cas9 in Duchenne – December 2016
On December 15, 2016, PPMD hosted a webinar with Dr. Eric Olson from the Department of Molecular Biology at UT Southwestern Medical Center to review the basics of gene editing and next steps in the research and development potential of CRISPR/Cas9 in Duchenne.
As you know, this holiday season PPMD is raising money to further explore the potential of gene editing technology like CRISPR/Cas9. But as with any new technology there are still many complex questions that must be answered as best we can, before it is ready to be tested in humans. This webinar reviewed the CRISPR technology and discussed two areas Dr. Olson and his team will first explore – how to test the efficacy and safety of dystrophins produced through this method.
If you haven’t already, please consider making a donation to our holiday campaign today—a donation that will be matched dollar for dollar by the Killian family until we have raised $250,000 to help us support gene transfer projects like CRISPR/Cas9. Donate today: http://www.parentprojectmd.org/seizethismoment
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.